Biogen Inc (BIIB)
141.44
+0.02
(+0.01%)
USD |
NASDAQ |
Mar 20, 16:00
141.44
0.00 (0.00%)
After-Hours: 20:00
Biogen Shareholders Equity (Quarterly): 16.72B for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly and Co | 14.19B |
| Sage Therapeutics Inc | 465.09M |
| Moderna Inc | 10.90B |
| Gilead Sciences Inc | 19.33B |
| Johnson & Johnson | 71.49B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 28.05B |
| Total Liabilities (Quarterly) | 11.33B |
| Debt to Equity Ratio | 0.3766 |
| Current Ratio | 1.349 |
| Net Debt Paydown Yield | 0.89% |